

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 7.73357530 |
| 2 | immunoglobulin mediated immune response (GO:0016064) | 6.09207615 |
| 3 | L-fucose catabolic process (GO:0042355) | 6.07683917 |
| 4 | fucose catabolic process (GO:0019317) | 6.07683917 |
| 5 | L-fucose metabolic process (GO:0042354) | 6.07683917 |
| 6 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 5.84341699 |
| 7 | negative regulation of mast cell activation (GO:0033004) | 5.25815957 |
| 8 | cytidine deamination (GO:0009972) | 5.24502692 |
| 9 | cytidine metabolic process (GO:0046087) | 5.24502692 |
| 10 | cytidine catabolic process (GO:0006216) | 5.24502692 |
| 11 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 5.01828909 |
| 12 | protein deneddylation (GO:0000338) | 4.98127373 |
| 13 | B cell mediated immunity (GO:0019724) | 4.89971546 |
| 14 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.86811619 |
| 15 | cullin deneddylation (GO:0010388) | 4.86008656 |
| 16 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 4.85292301 |
| 17 | positive thymic T cell selection (GO:0045059) | 4.77839509 |
| 18 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.46211000 |
| 19 | positive regulation of antigen processing and presentation (GO:0002579) | 4.43940571 |
| 20 | regulation of antigen processing and presentation (GO:0002577) | 4.43856212 |
| 21 | fusion of sperm to egg plasma membrane (GO:0007342) | 4.37961264 |
| 22 | negative thymic T cell selection (GO:0045060) | 4.34595463 |
| 23 | actin nucleation (GO:0045010) | 4.34035868 |
| 24 | negative T cell selection (GO:0043383) | 4.22893821 |
| 25 | mast cell degranulation (GO:0043303) | 4.10949680 |
| 26 | mast cell activation involved in immune response (GO:0002279) | 4.10949680 |
| 27 | T cell costimulation (GO:0031295) | 3.84857501 |
| 28 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.83308331 |
| 29 | lymphocyte costimulation (GO:0031294) | 3.79444417 |
| 30 | platelet dense granule organization (GO:0060155) | 3.70849687 |
| 31 | positive T cell selection (GO:0043368) | 3.68707875 |
| 32 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.66346056 |
| 33 | mast cell activation (GO:0045576) | 3.64276488 |
| 34 | negative regulation of actin filament bundle assembly (GO:0032232) | 3.58010163 |
| 35 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.43090899 |
| 36 | thymic T cell selection (GO:0045061) | 3.41904651 |
| 37 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.40358766 |
| 38 | negative regulation of B cell apoptotic process (GO:0002903) | 3.33448088 |
| 39 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.30897277 |
| 40 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.30106499 |
| 41 | T cell receptor signaling pathway (GO:0050852) | 3.29886773 |
| 42 | GDP-mannose metabolic process (GO:0019673) | 3.26386234 |
| 43 | plasma membrane fusion (GO:0045026) | 3.25533460 |
| 44 | regulation of chronic inflammatory response (GO:0002676) | 3.21579663 |
| 45 | glutathione biosynthetic process (GO:0006750) | 3.19630158 |
| 46 | fucose metabolic process (GO:0006004) | 3.18857144 |
| 47 | negative regulation of viral genome replication (GO:0045071) | 3.16263517 |
| 48 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.15951263 |
| 49 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.11161321 |
| 50 | regulation of T cell tolerance induction (GO:0002664) | 3.11032772 |
| 51 | regulation of lamellipodium assembly (GO:0010591) | 3.09487424 |
| 52 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.08439974 |
| 53 | fucosylation (GO:0036065) | 3.08069920 |
| 54 | positive regulation of tolerance induction (GO:0002645) | 3.04810286 |
| 55 | regulation of activation of Janus kinase activity (GO:0010533) | 3.03597711 |
| 56 | respiratory burst (GO:0045730) | 2.95024651 |
| 57 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.94946036 |
| 58 | regulation of regulatory T cell differentiation (GO:0045589) | 2.93951117 |
| 59 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.92128001 |
| 60 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.90614010 |
| 61 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.87980539 |
| 62 | sulfation (GO:0051923) | 2.87597020 |
| 63 | regulation of interleukin-8 secretion (GO:2000482) | 2.86819910 |
| 64 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.84881753 |
| 65 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.83896201 |
| 66 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.83080409 |
| 67 | positive regulation of cell killing (GO:0031343) | 2.81944160 |
| 68 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.79546362 |
| 69 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.77672033 |
| 70 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.75561576 |
| 71 | response to pheromone (GO:0019236) | 2.73808071 |
| 72 | negative regulation of T cell apoptotic process (GO:0070233) | 2.73778513 |
| 73 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.73257931 |
| 74 | inositol phosphate dephosphorylation (GO:0046855) | 2.73257931 |
| 75 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.72272635 |
| 76 | regulation of mast cell activation (GO:0033003) | 2.72107452 |
| 77 | UTP metabolic process (GO:0046051) | 2.72017727 |
| 78 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.70184830 |
| 79 | positive regulation of lamellipodium assembly (GO:0010592) | 2.69911323 |
| 80 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.69649032 |
| 81 | neuronal action potential propagation (GO:0019227) | 2.69327779 |
| 82 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.68912241 |
| 83 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.68912241 |
| 84 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.68912241 |
| 85 | xenobiotic catabolic process (GO:0042178) | 2.67516664 |
| 86 | GPI anchor biosynthetic process (GO:0006506) | 2.67420505 |
| 87 | positive regulation of actin filament polymerization (GO:0030838) | 2.66657235 |
| 88 | lysosome localization (GO:0032418) | 2.66319522 |
| 89 | positive regulation of chemokine secretion (GO:0090197) | 2.65333850 |
| 90 | cellular response to interferon-gamma (GO:0071346) | 2.64971261 |
| 91 | AMP metabolic process (GO:0046033) | 2.64677775 |
| 92 | T cell selection (GO:0045058) | 2.64329496 |
| 93 | positive regulation of T cell migration (GO:2000406) | 2.64058592 |
| 94 | T cell migration (GO:0072678) | 2.62127453 |
| 95 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.61325151 |
| 96 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.61325151 |
| 97 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.61156053 |
| 98 | regulation of tolerance induction (GO:0002643) | 2.60265294 |
| 99 | leukocyte degranulation (GO:0043299) | 2.58766300 |
| 100 | macrophage chemotaxis (GO:0048246) | 2.58726937 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.54798299 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.51033919 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.16001644 |
| 4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.10537411 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.77070000 |
| 6 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.66079744 |
| 7 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.62629954 |
| 8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.45729815 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.43830081 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.76129632 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.61631280 |
| 12 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.53433726 |
| 13 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.50587412 |
| 14 | MYB_26560356_Chip-Seq_TH2_Human | 2.29561996 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.29432617 |
| 16 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.29067491 |
| 17 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.20446590 |
| 18 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.11128649 |
| 19 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.08443806 |
| 20 | GATA3_26560356_Chip-Seq_TH2_Human | 1.99011161 |
| 21 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.97580811 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.95348314 |
| 23 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.88254592 |
| 24 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.84222518 |
| 25 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.81981143 |
| 26 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.81077165 |
| 27 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.80278123 |
| 28 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.79066771 |
| 29 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.74991625 |
| 30 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.74698127 |
| 31 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.66734695 |
| 32 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.58384222 |
| 33 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.58006441 |
| 34 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.54883132 |
| 35 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.52871310 |
| 36 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.51155199 |
| 37 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.49358823 |
| 38 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.43808329 |
| 39 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.40632121 |
| 40 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.39824393 |
| 41 | MYB_26560356_Chip-Seq_TH1_Human | 1.39634945 |
| 42 | SPI1_23127762_ChIP-Seq_K562_Human | 1.39000886 |
| 43 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.38450633 |
| 44 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.37640284 |
| 45 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.36575973 |
| 46 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.36568903 |
| 47 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34882728 |
| 48 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33605862 |
| 49 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.32585395 |
| 50 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32561378 |
| 51 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.31529141 |
| 52 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.27551785 |
| 53 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.26160531 |
| 54 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.24951295 |
| 55 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.22601557 |
| 56 | MAF_26560356_Chip-Seq_TH1_Human | 1.21937002 |
| 57 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.21570685 |
| 58 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19588930 |
| 59 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.17932848 |
| 60 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.17890445 |
| 61 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17058165 |
| 62 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.13059324 |
| 63 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.12673729 |
| 64 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11866502 |
| 65 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.11246844 |
| 66 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.10372198 |
| 67 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.08946256 |
| 68 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.08104267 |
| 69 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.08014376 |
| 70 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04678752 |
| 71 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.03617609 |
| 72 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03179098 |
| 73 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.02010355 |
| 74 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.01795463 |
| 75 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.00908070 |
| 76 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.00636569 |
| 77 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99535637 |
| 78 | UTX_26944678_Chip-Seq_JUKART_Human | 0.98701222 |
| 79 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.98680438 |
| 80 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.96907311 |
| 81 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.96648702 |
| 82 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.96145534 |
| 83 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.95958559 |
| 84 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94878735 |
| 85 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.93883104 |
| 86 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.93498201 |
| 87 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.93213564 |
| 88 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.92942725 |
| 89 | ERA_21632823_ChIP-Seq_H3396_Human | 0.91666062 |
| 90 | P300_27268052_Chip-Seq_Bcells_Human | 0.91461335 |
| 91 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.91327851 |
| 92 | MAF_26560356_Chip-Seq_TH2_Human | 0.87914561 |
| 93 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.85723130 |
| 94 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.85685048 |
| 95 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.85143903 |
| 96 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.84440150 |
| 97 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.84276595 |
| 98 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.83319372 |
| 99 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.83086670 |
| 100 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.82882943 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.94149310 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.87301355 |
| 3 | MP0002138_abnormal_hepatobiliary_system | 4.45114636 |
| 4 | MP0009785_altered_susceptibility_to | 3.48254251 |
| 5 | MP0002166_altered_tumor_susceptibility | 3.12266233 |
| 6 | MP0002102_abnormal_ear_morphology | 2.91788497 |
| 7 | MP0005000_abnormal_immune_tolerance | 2.90556256 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 2.74573616 |
| 9 | MP0003724_increased_susceptibility_to | 2.52269870 |
| 10 | MP0000685_abnormal_immune_system | 2.50368109 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 2.45873346 |
| 12 | MP0001873_stomach_inflammation | 2.41111700 |
| 13 | MP0005025_abnormal_response_to | 2.33177684 |
| 14 | MP0003763_abnormal_thymus_physiology | 2.32941120 |
| 15 | MP0002006_tumorigenesis | 2.28435329 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.15147909 |
| 17 | MP0001800_abnormal_humoral_immune | 2.12841149 |
| 18 | MP0001819_abnormal_immune_cell | 2.12419234 |
| 19 | MP0002723_abnormal_immune_serum | 2.06260960 |
| 20 | MP0002405_respiratory_system_inflammati | 2.04321020 |
| 21 | MP0005451_abnormal_body_composition | 2.04110338 |
| 22 | MP0006054_spinal_hemorrhage | 1.97780445 |
| 23 | MP0009333_abnormal_splenocyte_physiolog | 1.96787603 |
| 24 | MP0005387_immune_system_phenotype | 1.86896027 |
| 25 | MP0001790_abnormal_immune_system | 1.86896027 |
| 26 | MP0002452_abnormal_antigen_presenting | 1.80960597 |
| 27 | MP0003436_decreased_susceptibility_to | 1.80036330 |
| 28 | MP0003866_abnormal_defecation | 1.73783682 |
| 29 | MP0002398_abnormal_bone_marrow | 1.69167197 |
| 30 | MP0010155_abnormal_intestine_physiology | 1.67281472 |
| 31 | MP0002419_abnormal_innate_immunity | 1.64711828 |
| 32 | MP0000465_gastrointestinal_hemorrhage | 1.62161134 |
| 33 | MP0000716_abnormal_immune_system | 1.61940310 |
| 34 | MP0001845_abnormal_inflammatory_respons | 1.56687982 |
| 35 | MP0000689_abnormal_spleen_morphology | 1.54236670 |
| 36 | MP0002722_abnormal_immune_system | 1.44065455 |
| 37 | MP0003183_abnormal_peptide_metabolism | 1.39535919 |
| 38 | MP0006036_abnormal_mitochondrial_physio | 1.39202102 |
| 39 | MP0009764_decreased_sensitivity_to | 1.38785668 |
| 40 | MP0002429_abnormal_blood_cell | 1.36422980 |
| 41 | MP0006082_CNS_inflammation | 1.32799952 |
| 42 | MP0001764_abnormal_homeostasis | 1.27284320 |
| 43 | MP0005464_abnormal_platelet_physiology | 1.25922140 |
| 44 | MP0005377_hearing/vestibular/ear_phenot | 1.24619253 |
| 45 | MP0003878_abnormal_ear_physiology | 1.24619253 |
| 46 | MP0000703_abnormal_thymus_morphology | 1.24363234 |
| 47 | MP0008469_abnormal_protein_level | 1.22318840 |
| 48 | MP0003195_calcinosis | 1.21966072 |
| 49 | MP0003448_altered_tumor_morphology | 1.21884765 |
| 50 | MP0005166_decreased_susceptibility_to | 1.16919355 |
| 51 | MP0005410_abnormal_fertilization | 1.16004443 |
| 52 | MP0005075_abnormal_melanosome_morpholog | 1.15476841 |
| 53 | MP0008872_abnormal_physiological_respon | 1.10976040 |
| 54 | MP0001533_abnormal_skeleton_physiology | 1.07277216 |
| 55 | MP0002876_abnormal_thyroid_physiology | 1.06249837 |
| 56 | MP0002933_joint_inflammation | 1.05988237 |
| 57 | MP0004147_increased_porphyrin_level | 1.04877573 |
| 58 | MP0005645_abnormal_hypothalamus_physiol | 1.02508005 |
| 59 | MP0005332_abnormal_amino_acid | 1.01385565 |
| 60 | MP0000613_abnormal_salivary_gland | 1.00847458 |
| 61 | MP0003303_peritoneal_inflammation | 0.99277965 |
| 62 | MP0005085_abnormal_gallbladder_physiolo | 0.93950808 |
| 63 | MP0002019_abnormal_tumor_incidence | 0.91470203 |
| 64 | MP0009763_increased_sensitivity_to | 0.91131445 |
| 65 | MP0005058_abnormal_lysosome_morphology | 0.89971324 |
| 66 | MP0004782_abnormal_surfactant_physiolog | 0.89953698 |
| 67 | MP0008873_increased_physiological_sensi | 0.89160653 |
| 68 | MP0001663_abnormal_digestive_system | 0.87587190 |
| 69 | MP0009643_abnormal_urine_homeostasis | 0.87271159 |
| 70 | MP0009697_abnormal_copulation | 0.87002247 |
| 71 | MP0001666_abnormal_nutrient_absorption | 0.86604613 |
| 72 | MP0003693_abnormal_embryo_hatching | 0.85302108 |
| 73 | MP0008260_abnormal_autophagy | 0.84670518 |
| 74 | MP0001501_abnormal_sleep_pattern | 0.83836893 |
| 75 | MP0003045_fibrosis | 0.83597610 |
| 76 | MP0009840_abnormal_foam_cell | 0.81229731 |
| 77 | MP0001919_abnormal_reproductive_system | 0.80864907 |
| 78 | MP0001905_abnormal_dopamine_level | 0.80283782 |
| 79 | MP0005636_abnormal_mineral_homeostasis | 0.75828023 |
| 80 | MP0000858_altered_metastatic_potential | 0.75316615 |
| 81 | MP0006072_abnormal_retinal_apoptosis | 0.75168156 |
| 82 | MP0008875_abnormal_xenobiotic_pharmacok | 0.75138574 |
| 83 | MP0001243_abnormal_dermal_layer | 0.72498004 |
| 84 | MP0003186_abnormal_redox_activity | 0.70048356 |
| 85 | MP0002277_abnormal_respiratory_mucosa | 0.67505807 |
| 86 | MP0005365_abnormal_bile_salt | 0.66406382 |
| 87 | MP0003252_abnormal_bile_duct | 0.65419789 |
| 88 | MP0004742_abnormal_vestibular_system | 0.64868813 |
| 89 | MP0001853_heart_inflammation | 0.64853236 |
| 90 | MP0003075_altered_response_to | 0.64826876 |
| 91 | MP0005551_abnormal_eye_electrophysiolog | 0.64306087 |
| 92 | MP0002136_abnormal_kidney_physiology | 0.61115642 |
| 93 | MP0005084_abnormal_gallbladder_morpholo | 0.58738323 |
| 94 | MP0001986_abnormal_taste_sensitivity | 0.58412993 |
| 95 | MP0000490_abnormal_crypts_of | 0.57946335 |
| 96 | MP0003011_delayed_dark_adaptation | 0.57159863 |
| 97 | MP0008438_abnormal_cutaneous_collagen | 0.56056738 |
| 98 | MP0002733_abnormal_thermal_nociception | 0.56012251 |
| 99 | MP0008995_early_reproductive_senescence | 0.55494342 |
| 100 | MP0005319_abnormal_enzyme/_coenzyme | 0.55468221 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypomagnesemia (HP:0002917) | 5.29894928 |
| 2 | Abnormality of the prostate (HP:0008775) | 5.27153058 |
| 3 | Prostate neoplasm (HP:0100787) | 4.98639918 |
| 4 | Abnormality of magnesium homeostasis (HP:0004921) | 4.67852895 |
| 5 | Increased IgM level (HP:0003496) | 4.25396563 |
| 6 | Abnormality of T cell number (HP:0011839) | 3.99144259 |
| 7 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 3.93741884 |
| 8 | T lymphocytopenia (HP:0005403) | 3.80255305 |
| 9 | IgG deficiency (HP:0004315) | 3.68490337 |
| 10 | Autoimmune hemolytic anemia (HP:0001890) | 3.67408207 |
| 11 | J-shaped sella turcica (HP:0002680) | 3.55295030 |
| 12 | Hypoproteinemia (HP:0003075) | 3.55250134 |
| 13 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.49134574 |
| 14 | Abnormality of T cells (HP:0002843) | 3.40478553 |
| 15 | Abnormality of male internal genitalia (HP:0000022) | 3.20097732 |
| 16 | Aplastic anemia (HP:0001915) | 3.11699911 |
| 17 | Abnormality of B cell number (HP:0010975) | 3.09732953 |
| 18 | Abnormality of midbrain morphology (HP:0002418) | 3.09490353 |
| 19 | Molar tooth sign on MRI (HP:0002419) | 3.09490353 |
| 20 | Pulmonary fibrosis (HP:0002206) | 3.07901740 |
| 21 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 3.04104243 |
| 22 | Absent epiphyses (HP:0010577) | 3.04104243 |
| 23 | Obstructive lung disease (HP:0006536) | 2.95116299 |
| 24 | Chronic obstructive pulmonary disease (HP:0006510) | 2.95116299 |
| 25 | Stomach cancer (HP:0012126) | 2.92116955 |
| 26 | Retinal dysplasia (HP:0007973) | 2.85867845 |
| 27 | Progressive neurologic deterioration (HP:0002344) | 2.85045318 |
| 28 | Abolished electroretinogram (ERG) (HP:0000550) | 2.82068750 |
| 29 | Meningitis (HP:0001287) | 2.79213492 |
| 30 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.77860943 |
| 31 | Increased serum lactate (HP:0002151) | 2.65283060 |
| 32 | Amyotrophic lateral sclerosis (HP:0007354) | 2.64076226 |
| 33 | Type 2 muscle fiber atrophy (HP:0003554) | 2.62218349 |
| 34 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.61040546 |
| 35 | Recurrent cutaneous fungal infections (HP:0011370) | 2.58823385 |
| 36 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.58823385 |
| 37 | Chronic hepatic failure (HP:0100626) | 2.58178537 |
| 38 | Pulmonary infiltrates (HP:0002113) | 2.56802088 |
| 39 | Polyuria (HP:0000103) | 2.53827405 |
| 40 | Periorbital edema (HP:0100539) | 2.52294931 |
| 41 | Recurrent bacterial skin infections (HP:0005406) | 2.49189956 |
| 42 | Abnormality of T cell physiology (HP:0011840) | 2.48147252 |
| 43 | Hyponatremia (HP:0002902) | 2.46108999 |
| 44 | IgM deficiency (HP:0002850) | 2.44957752 |
| 45 | Renal salt wasting (HP:0000127) | 2.44278203 |
| 46 | Facial edema (HP:0000282) | 2.42743359 |
| 47 | Alkalosis (HP:0001948) | 2.42433544 |
| 48 | Hepatocellular necrosis (HP:0001404) | 2.42400373 |
| 49 | Autoimmune thrombocytopenia (HP:0001973) | 2.42131143 |
| 50 | Attenuation of retinal blood vessels (HP:0007843) | 2.41643164 |
| 51 | Delayed CNS myelination (HP:0002188) | 2.37224674 |
| 52 | Hepatic necrosis (HP:0002605) | 2.36654365 |
| 53 | Microvesicular hepatic steatosis (HP:0001414) | 2.34138541 |
| 54 | Recurrent fungal infections (HP:0002841) | 2.32543731 |
| 55 | Mediastinal lymphadenopathy (HP:0100721) | 2.32319952 |
| 56 | Infantile muscular hypotonia (HP:0008947) | 2.29868808 |
| 57 | Muscle fiber atrophy (HP:0100295) | 2.28173044 |
| 58 | Urticaria (HP:0001025) | 2.26758222 |
| 59 | Pustule (HP:0200039) | 2.23593742 |
| 60 | Recurrent abscess formation (HP:0002722) | 2.22643256 |
| 61 | Encephalitis (HP:0002383) | 2.16966187 |
| 62 | Absent/shortened dynein arms (HP:0200106) | 2.14063709 |
| 63 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.14063709 |
| 64 | B lymphocytopenia (HP:0010976) | 2.13125014 |
| 65 | Ureteral stenosis (HP:0000071) | 2.12161176 |
| 66 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.10785586 |
| 67 | Abnormality of macrophages (HP:0004311) | 2.10574491 |
| 68 | Chest pain (HP:0100749) | 2.10532321 |
| 69 | Abnormal urine output (HP:0012590) | 2.10392578 |
| 70 | Ureteral obstruction (HP:0006000) | 2.07604627 |
| 71 | Decreased central vision (HP:0007663) | 2.06631507 |
| 72 | Eosinophilia (HP:0001880) | 2.04900824 |
| 73 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.04546831 |
| 74 | Type I transferrin isoform profile (HP:0003642) | 2.03977807 |
| 75 | Eczematoid dermatitis (HP:0000976) | 2.02826319 |
| 76 | Abnormality of eosinophils (HP:0001879) | 1.99578134 |
| 77 | Elfin facies (HP:0004428) | 1.99154620 |
| 78 | Lactic acidosis (HP:0003128) | 1.98041720 |
| 79 | Hypercalciuria (HP:0002150) | 1.97288033 |
| 80 | Overriding aorta (HP:0002623) | 1.96768429 |
| 81 | Acute necrotizing encephalopathy (HP:0006965) | 1.93908488 |
| 82 | Generalized aminoaciduria (HP:0002909) | 1.93603040 |
| 83 | Increased intramyocellular lipid droplets (HP:0012240) | 1.93459882 |
| 84 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.93080195 |
| 85 | Hemoptysis (HP:0002105) | 1.92832583 |
| 86 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.92166370 |
| 87 | Recurrent skin infections (HP:0001581) | 1.91700662 |
| 88 | Agammaglobulinemia (HP:0004432) | 1.89594456 |
| 89 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.87998711 |
| 90 | Chronic diarrhea (HP:0002028) | 1.87171912 |
| 91 | Petechiae (HP:0000967) | 1.86628627 |
| 92 | Stomatitis (HP:0010280) | 1.86375417 |
| 93 | Vasculitis (HP:0002633) | 1.85156440 |
| 94 | Agitation (HP:0000713) | 1.84990079 |
| 95 | Lymphopenia (HP:0001888) | 1.84946155 |
| 96 | Mitochondrial inheritance (HP:0001427) | 1.84823035 |
| 97 | Acute hepatic failure (HP:0006554) | 1.84722293 |
| 98 | Recurrent viral infections (HP:0004429) | 1.84705694 |
| 99 | Renovascular hypertension (HP:0100817) | 1.83406225 |
| 100 | Abnormality of the pleura (HP:0002103) | 1.83034102 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDR | 5.56615838 |
| 2 | SCYL2 | 4.72205193 |
| 3 | TESK2 | 4.52314168 |
| 4 | TLK1 | 4.46847813 |
| 5 | ZAK | 4.31943934 |
| 6 | KIT | 3.63726267 |
| 7 | MAP4K1 | 3.23910328 |
| 8 | FES | 2.68325580 |
| 9 | FER | 2.18814927 |
| 10 | TXK | 2.11726998 |
| 11 | SYK | 2.08159075 |
| 12 | CDK8 | 2.00364822 |
| 13 | TESK1 | 1.85343693 |
| 14 | GRK1 | 1.71129582 |
| 15 | MAP4K2 | 1.68160290 |
| 16 | TAOK3 | 1.64869480 |
| 17 | ITK | 1.62602598 |
| 18 | TBK1 | 1.56627339 |
| 19 | VRK2 | 1.55066980 |
| 20 | CSF1R | 1.42719678 |
| 21 | IKBKE | 1.42505671 |
| 22 | LIMK1 | 1.38438784 |
| 23 | GRK6 | 1.34123858 |
| 24 | PINK1 | 1.30776063 |
| 25 | MAPKAPK3 | 1.24926643 |
| 26 | MST4 | 1.23628916 |
| 27 | ADRBK2 | 1.17434845 |
| 28 | TEC | 1.15334590 |
| 29 | LYN | 1.11813780 |
| 30 | RPS6KA4 | 1.11542160 |
| 31 | PHKG2 | 1.09287423 |
| 32 | PHKG1 | 1.09287423 |
| 33 | MAP3K11 | 1.09226082 |
| 34 | PDK2 | 0.98596430 |
| 35 | CSK | 0.97708446 |
| 36 | LCK | 0.93003493 |
| 37 | MAP3K12 | 0.90264982 |
| 38 | VRK1 | 0.89808006 |
| 39 | TNK2 | 0.89495122 |
| 40 | JAK3 | 0.86569849 |
| 41 | ATR | 0.84798239 |
| 42 | ZAP70 | 0.83808512 |
| 43 | NME1 | 0.81413040 |
| 44 | RIPK4 | 0.80325180 |
| 45 | IKBKB | 0.79506578 |
| 46 | PIK3CG | 0.78060169 |
| 47 | DAPK2 | 0.76814595 |
| 48 | FLT3 | 0.76184099 |
| 49 | TYRO3 | 0.75735628 |
| 50 | IRAK4 | 0.75341433 |
| 51 | BTK | 0.70372599 |
| 52 | PRKCQ | 0.67881082 |
| 53 | BMPR1B | 0.66933862 |
| 54 | PIK3CA | 0.66652311 |
| 55 | BCKDK | 0.65277930 |
| 56 | BRSK2 | 0.64958580 |
| 57 | CDK4 | 0.61542927 |
| 58 | BLK | 0.59098402 |
| 59 | SIK3 | 0.58479982 |
| 60 | DAPK1 | 0.54842106 |
| 61 | WNK3 | 0.53980330 |
| 62 | RPS6KA5 | 0.53450379 |
| 63 | CAMKK1 | 0.51534731 |
| 64 | MAPK13 | 0.51198210 |
| 65 | PIM1 | 0.50457419 |
| 66 | MATK | 0.43768136 |
| 67 | ABL1 | 0.43409546 |
| 68 | CDK3 | 0.40899484 |
| 69 | IGF1R | 0.40571924 |
| 70 | NUAK1 | 0.40139080 |
| 71 | WNK4 | 0.38950894 |
| 72 | PRKCA | 0.38564998 |
| 73 | MYLK | 0.38533626 |
| 74 | GRK7 | 0.38484662 |
| 75 | CAMKK2 | 0.37104248 |
| 76 | HCK | 0.32914283 |
| 77 | INSRR | 0.31568462 |
| 78 | MAP2K2 | 0.31563860 |
| 79 | PIM2 | 0.29755566 |
| 80 | CDK9 | 0.28483157 |
| 81 | MAPKAPK2 | 0.27909295 |
| 82 | MAP3K5 | 0.27544222 |
| 83 | BMPR2 | 0.25368366 |
| 84 | PRKCI | 0.24353437 |
| 85 | AURKA | 0.23834454 |
| 86 | GRK5 | 0.23789854 |
| 87 | OXSR1 | 0.23778189 |
| 88 | MAP2K6 | 0.22904409 |
| 89 | MAPKAPK5 | 0.22248827 |
| 90 | TRPM7 | 0.21793140 |
| 91 | PRKCD | 0.21402561 |
| 92 | CDK19 | 0.21314477 |
| 93 | INSR | 0.20944881 |
| 94 | ADRBK1 | 0.19802184 |
| 95 | FYN | 0.17289595 |
| 96 | ERN1 | 0.16555220 |
| 97 | CSNK2A1 | 0.16439282 |
| 98 | PRKACA | 0.16253898 |
| 99 | BRSK1 | 0.16246036 |
| 100 | ATM | 0.14973209 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.79091557 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 4.72037453 |
| 3 | Asthma_Homo sapiens_hsa05310 | 4.67896917 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 4.41203271 |
| 5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.90751038 |
| 6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.79490313 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.45444708 |
| 8 | Proteasome_Homo sapiens_hsa03050 | 3.25125287 |
| 9 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.72028305 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.58025298 |
| 11 | Viral myocarditis_Homo sapiens_hsa05416 | 2.42164134 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.36237209 |
| 13 | Leishmaniasis_Homo sapiens_hsa05140 | 2.21473421 |
| 14 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.21145455 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.97768508 |
| 16 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.69169364 |
| 17 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.54576228 |
| 18 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.48937453 |
| 19 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.44960802 |
| 20 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.35029465 |
| 21 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.25963751 |
| 22 | Parkinsons disease_Homo sapiens_hsa05012 | 1.25061550 |
| 23 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.22620931 |
| 24 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.21734601 |
| 25 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.17407327 |
| 26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.10112878 |
| 27 | Tuberculosis_Homo sapiens_hsa05152 | 1.04240006 |
| 28 | DNA replication_Homo sapiens_hsa03030 | 0.98340429 |
| 29 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.96486357 |
| 30 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.94186210 |
| 31 | RNA polymerase_Homo sapiens_hsa03020 | 0.88872694 |
| 32 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.85891873 |
| 33 | Malaria_Homo sapiens_hsa05144 | 0.80135403 |
| 34 | Legionellosis_Homo sapiens_hsa05134 | 0.79904441 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.76832532 |
| 36 | Phagosome_Homo sapiens_hsa04145 | 0.74424467 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 0.73691590 |
| 38 | Salmonella infection_Homo sapiens_hsa05132 | 0.71828131 |
| 39 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.70552628 |
| 40 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.65837605 |
| 41 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.64744090 |
| 42 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.63713149 |
| 43 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.62062428 |
| 44 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.61611228 |
| 45 | Mismatch repair_Homo sapiens_hsa03430 | 0.60480450 |
| 46 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.59592882 |
| 47 | Alzheimers disease_Homo sapiens_hsa05010 | 0.59013597 |
| 48 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.58673634 |
| 49 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.58463938 |
| 50 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.57622356 |
| 51 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55253143 |
| 52 | Base excision repair_Homo sapiens_hsa03410 | 0.55107319 |
| 53 | Shigellosis_Homo sapiens_hsa05131 | 0.54971883 |
| 54 | Pertussis_Homo sapiens_hsa05133 | 0.54895561 |
| 55 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.50472913 |
| 56 | Huntingtons disease_Homo sapiens_hsa05016 | 0.49645659 |
| 57 | Measles_Homo sapiens_hsa05162 | 0.49258102 |
| 58 | Purine metabolism_Homo sapiens_hsa00230 | 0.46227063 |
| 59 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.45819119 |
| 60 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.44709958 |
| 61 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.43968493 |
| 62 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.42935347 |
| 63 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.41129656 |
| 64 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.41083649 |
| 65 | RNA degradation_Homo sapiens_hsa03018 | 0.41053855 |
| 66 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.40589840 |
| 67 | Phototransduction_Homo sapiens_hsa04744 | 0.39524804 |
| 68 | Protein export_Homo sapiens_hsa03060 | 0.38999608 |
| 69 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.38560982 |
| 70 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.36384562 |
| 71 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.36319478 |
| 72 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.32315433 |
| 73 | Peroxisome_Homo sapiens_hsa04146 | 0.32235940 |
| 74 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.30966618 |
| 75 | HTLV-I infection_Homo sapiens_hsa05166 | 0.29012719 |
| 76 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.28641316 |
| 77 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.28426653 |
| 78 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.28385794 |
| 79 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.26881455 |
| 80 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.25929946 |
| 81 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.25498605 |
| 82 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.23956620 |
| 83 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.22663817 |
| 84 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.22499117 |
| 85 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.22475131 |
| 86 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.21309528 |
| 87 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.20654779 |
| 88 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.18494721 |
| 89 | ABC transporters_Homo sapiens_hsa02010 | 0.18470384 |
| 90 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.18465410 |
| 91 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.17552048 |
| 92 | Platelet activation_Homo sapiens_hsa04611 | 0.16571031 |
| 93 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.16024007 |
| 94 | Metabolic pathways_Homo sapiens_hsa01100 | 0.15145413 |
| 95 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.14045213 |
| 96 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.13283223 |
| 97 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.12564762 |
| 98 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.11662936 |
| 99 | Retinol metabolism_Homo sapiens_hsa00830 | 0.11347499 |
| 100 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.11037873 |

